Pe Dejong

423 total citations
19 papers, 330 citations indexed

About

Pe Dejong is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pe Dejong has authored 19 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Nephrology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pe Dejong's work include Hormonal Regulation and Hypertension (3 papers), Electrolyte and hormonal disorders (2 papers) and Renin-Angiotensin System Studies (2 papers). Pe Dejong is often cited by papers focused on Hormonal Regulation and Hypertension (3 papers), Electrolyte and hormonal disorders (2 papers) and Renin-Angiotensin System Studies (2 papers). Pe Dejong collaborates with scholars based in Pakistan and Netherlands. Pe Dejong's co-authors include Dick de Zeeuw, A J Apperloo, GJ Navis, R. Vriesendorp, Gert Mayer, Alice Schmidt, Mark Haas, Ajm Donker, W. M. T. Janssen and NH Mulder and has published in prestigious journals such as Cancer Chemotherapy and Pharmacology, The Netherlands Journal of Medicine and Data Archiving and Networked Services (DANS).

In The Last Decade

Pe Dejong

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pe Dejong Pakistan 9 152 148 103 38 35 19 330
P.E. de Jong Netherlands 12 172 1.1× 189 1.3× 103 1.0× 103 2.7× 29 0.8× 15 415
A J Apperloo Netherlands 6 235 1.5× 194 1.3× 144 1.4× 58 1.5× 13 0.4× 7 419
T Kitajima Japan 7 237 1.6× 196 1.3× 158 1.5× 44 1.2× 26 0.7× 13 434
Gen Futaki Japan 4 186 1.2× 160 1.1× 146 1.4× 42 1.1× 11 0.3× 7 362
Makoto Ishizaki Japan 7 193 1.3× 190 1.3× 146 1.4× 57 1.5× 12 0.3× 31 457
Vincenzo Gambara Italy 5 147 1.0× 370 2.5× 159 1.5× 76 2.0× 37 1.1× 7 509
J. Chahin Spain 9 62 0.4× 311 2.1× 94 0.9× 34 0.9× 22 0.6× 14 445
Nobuyoshi Takagi Japan 12 156 1.0× 85 0.6× 110 1.1× 33 0.9× 15 0.4× 32 371
Jun Koshimura Japan 11 86 0.6× 152 1.0× 108 1.0× 47 1.2× 25 0.7× 18 491
Ichiyu Shou Japan 11 78 0.5× 178 1.2× 39 0.4× 49 1.3× 17 0.5× 27 337

Countries citing papers authored by Pe Dejong

Since Specialization
Citations

This map shows the geographic impact of Pe Dejong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pe Dejong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pe Dejong more than expected).

Fields of papers citing papers by Pe Dejong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pe Dejong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pe Dejong. The network helps show where Pe Dejong may publish in the future.

Co-authorship network of co-authors of Pe Dejong

This figure shows the co-authorship network connecting the top 25 collaborators of Pe Dejong. A scholar is included among the top collaborators of Pe Dejong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pe Dejong. Pe Dejong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Buter, Hanneke, et al.. (1997). Is the antiproteinuric response to inhibition of the renin-angiotensin system less effective during the night?. PubMed. 12 Suppl 2. 53–6. 5 indexed citations
2.
Navis, G., et al.. (1997). 38. ACE gene polymorphism does not determine short-term renal response to ACE inhibition in proteinuric patients. The Netherlands Journal of Medicine. 50(5). A15–A15. 1 indexed citations
3.
Zeeuw, Dick de, et al.. (1997). Measurement of glomerular charge selectivity in non-diabetic renal disease.. PubMed. 12 Suppl 2. 57–62. 8 indexed citations
4.
Schmidt, Alice, GJ Navis, Mark Haas, et al.. (1997). Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.. PubMed. 63. S23–6. 47 indexed citations
5.
Dejong, Pe, Dick de Zeeuw, & Mogensen Ce. (1997). Proteinuria and Progressive Renal Disease - June 1996 - Amsterdam, The Netherlands - Introduction. 12. 1–1. 4 indexed citations
6.
Buter, Hanneke, GJ Navis, Dick de Zeeuw, & Pe Dejong. (1997). Renal hemodynamic effects of candesartan in normal and impaired renal function in humans.. PubMed. 63. S185–7. 9 indexed citations
7.
Dejong, Pe, et al.. (1996). Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.. PubMed. 4 Suppl 1. 47–52. 33 indexed citations
8.
Janssen, W. M. T., Pe Dejong, & Dick de Zeeuw. (1996). Hypertension and renal disease: role of microalbuminuria.. PubMed. 14(5). S173–7. 18 indexed citations
9.
Stegeman, Coen A., et al.. (1995). FLUCTUATIONS OF UREA GENERATION RATE FOLLOWING PROTEIN-INTAKE IN HEMODIALYSIS-PATIENTS MEASURED USING [C-13]UREA. Data Archiving and Networked Services (DANS). 6(3). 581–581. 2 indexed citations
10.
Stegeman, Coen A., et al.. (1995). CARBAMYLATED HEMOGLOBIN - AN UREA-DERIVED INDEX OF UREMIA. Data Archiving and Networked Services (DANS). 47(4). 1219–1220. 1 indexed citations
11.
Stegeman, Coen A., et al.. (1995). THE ERYTHROPOIETIN DOSE CORRELATES WITH DIALYSIS ADEQUACY IN PATIENTS ON CHRONIC-HEMODIALYSIS. Data Archiving and Networked Services (DANS). 6(3). 563–563. 7 indexed citations
12.
Apperloo, A J, Dick de Zeeuw, & Pe Dejong. (1994). Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease.. PubMed. 45. S174–8. 109 indexed citations
13.
Vriesendorp, R., et al.. (1986). Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.. PubMed. 25(2). 105–10. 33 indexed citations
14.
Huisman, R. M., et al.. (1986). Nephrotic syndrome preceding Hodgkin's disease by 42 months.. PubMed. 26(6). 311–3. 9 indexed citations
15.
Navis, GJ, Dick de Zeeuw, & Pe Dejong. (1986). Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.. PubMed. 8 Suppl 1. S30–4. 13 indexed citations
16.
Dejong, Pe, et al.. (1986). Short-term effects of percutaneous transluminal renal angioplasty on renal function in unilateral renal artery stenosis.. PubMed. 29(11). 347–51. 1 indexed citations
17.
Dejong, Pe, et al.. (1986). Atrial natriuretic peptides: a new dimension in the understanding of volume homoeostasis?. PubMed. 29(5). 170–4.
18.
Meijer, S., NH Mulder, D.Th. Sleijfer, et al.. (1982). Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma. Cancer Chemotherapy and Pharmacology. 8(1). 27–30. 27 indexed citations
19.
Dejong, Pe, et al.. (1978). The role of prostaglandins and renin in sickle-cell nephropathy. A hypothesis.. The Netherlands Journal of Medicine. 21(2). 67–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026